Metastatic Hormone Refractory Prostate Cancer Active Not Recruiting Phase 2 Trials for Indoximod (DB12827)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01560923Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerTreatment